Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Jetrea Generic Name & Formulations
Legal Class
Rx
General Description
Ocriplasmin 2.5mg/mL; per vial; soln for intravitreal inj after dilution; contains mannitol; preservative- and latex-free.
Pharmacological Class
Proteolytic enzyme.
How Supplied
Single-use vial (0.2mL)—1
Manufacturer
Generic Availability
NO
Jetrea Indications
Indications
Treatment of symptomatic vitreomacular adhesion.
Jetrea Dosage and Administration
Adult
Give by intravitreal inj. 0.125mg (0.1mL of the diluted soln) once as a single dose to the affected eye.
Children
Not recommended.
Jetrea Contraindications
Not Applicable
Jetrea Boxed Warnings
Not Applicable
Jetrea Warnings/Precautions
Warnings/Precautions
For ophthalmic intravitreal inj only. Monitor for elevation in intraocular pressure immediately after inj. Monitor for decreased vision. Repeated administration in the same eye: not recommended. Treatment in the other eye is not recommended within 7 days of the initial inj. Pregnancy (Cat.C). Nursing mothers.
Jetrea Pharmacokinetics
See Literature
Jetrea Interactions
Not Applicable
Jetrea Adverse Reactions
Adverse Reactions
Vitreous floaters, conjunctival hemorrhage, eye pain, photopsia, blurred vision, macular hole, reduced visual acuity, visual impairment, retinal edema; intraocular inflammation/infection/hemorrhage, increased intraocular pressure, yellowish vision.
Jetrea Clinical Trials
See Literature
Jetrea Note
Not Applicable
Jetrea Patient Counseling
See Literature
